Evidence map›Paper›PMID 31953486›Full record

ArticleScientific reports2020

Endothelial Autophagy: an Effective Target for Radiation-induced Cerebral Capillary Damage.

Xiaolin Ai, Zengpanpan Ye, Yuqin Yao, Jianghong Xiao, Chao You, Jianguo Xu, Xi Huang, Jian Zhong, Min Fan, Xuejiao Song and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Xiaolin Ai *State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China.
Zengpanpan Ye *State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China.
Yuqin YaoWest China School of Public Health, No.4 West China Teaching Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Jianghong XiaoState Key Laboratory of Biotherapy and Department of Head and Neck Oncology, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, P. R. China.
Chao YouDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Jianguo XuDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Xi HuangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China.
Jian ZhongState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China.
Min FanDepartment of Imaging, West China Hospital of Sichuan University, Chengdu, Sichuan, P. R. China.
Xuejiao SongWest China School of Public Health, No.4 West China Teaching Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Huashan ShiWest China School of Public Health, No.4 West China Teaching Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Dongmei ZhangDepartment of Gynecology and Obstetrics, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China. chjianzhao@scu.edu.cn.
Chengjian ZhaoState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China. 392921842@qq.com.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxicity to central nervous system tissues is the common side effects for radiotherapy of brain tumor. The radiation toxicity has been thought to be related to the damage of cerebral endothelium. However, because of lacking a suitable high-resolution vivo model, cellular response of cerebral capillaries to radiation remained unclear. Here, we present the flk:eGFP transgenic zebrafish larvae as a feasible model to study the radiation toxicity to cerebral capillary. We showed that, in living zebrafish larvae, radiation could induce acute cerebral capillary shrinkage and blood-flow obstruction, resulting brain hypoxia and glycolysis retardant. Although in vivo neuron damage was also observed after the radiation exposure, further investigation found that they didn't response to the same dosage of radiation in vitro, indicating that radiation induced neuron damage was a secondary-effect of cerebral vascular function damage. In addition, transgenic labeling and qPCR results showed that the radiation-induced acute cerebral endothelial damage was correlated with intensive endothelial autophagy. Different autophagy inhibitors could significantly alleviate the radiation-induced cerebral capillary damage and prolong the survival of zebrafish larvae. Therefore, we showed that radiation could directly damage cerebral capillary, resulting to blood flow deficiency and neuron death, which suggested endothelial autophagy as a potential target for radiation-induced brain toxicity.

Indexed as

AnimalsAnimals, Genetically ModifiedAutophagyBrainBrain InjuriesCells, CulturedCerebral AngiographyCoculture TechniquesCranial IrradiationDisease Models, AnimalEndotheliumGreen Fluorescent ProteinsMicroscopy, ConfocalMicrotubule-Associated ProteinsNeuronsTranscription Factorsfli1 protein, zebrafishGreen Fluorescent Proteinsmap1lc3b protein, zebrafishMicrotubule-Associated ProteinsTranscription FactorsZebrafish Proteins

Identifiers

PMID31953486
PMCPMC6968992
OpenAlexW3000519820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.